Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

New potential biomarkers for early-stage AD

July 22, 2015

OAT-449 shows in vitro efficacy as a microtubule-destabilizing compound

July 22, 2015

NEI starts phase I/II clinical study of AAV8-RS1 gene therapy for XLRS

July 22, 2015

TRV-101 reduces beta-amyloid and tau toxic aggregates in animal models of AD

July 21, 2015

SUVN-G3031 demonstrates procognitive effects without affecting sleep

July 21, 2015

Mesenchymal stem cell-derived exosomes can enhance wound healing

July 17, 2015

Kallikrein-11 shows potential as a brain tumor biomarker

July 17, 2015

Retinal degeneration model devised to test retinal sheet transplants

July 17, 2015

Nanocarrier formulation improves delivery of CsA to the eye

July 16, 2015

Pharmacological profile a novel FXIa inhibitor from Sumitomo Dainippon presented

July 16, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 5, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.